Showing results (911-920 of 945) with videos related to
Sort By:
Pageof 95
Journal of Medicinal Chemistry|January 24, 2003
Hybrid-designed inhibitors of p38 MAP kinase utilizing N-arylpyridazinonesSteven L Colletti, Jessica L Frie, Elizabeth C Dixon, et al.Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Novel heterocyclic glucocorticoids: in vitro profile and in vivo efficacyChristopher F Thompson, Nazia Quraishi, Amjad Ali, et al.Bioorganic & Medicinal Chemistry Letters|October 26, 2005
p38 MAP kinase inhibitors: metabolically stabilized piperidine-substituted quinolinones and naphthyridinonesJianming Bao, Julianne A Hunt, Shouwu Miao, et al.Bioorganic & Medicinal Chemistry Letters|May 1, 2007
Novel glucocorticoids containing a 6,5-bicyclic core fused to a pyrazole ring: synthesis, in vitro profile, molecular modeling studies, and in vivo experimentsChristopher F Thompson, Nazia Quraishi, Amjad Ali, et al.Nature Biomedical Engineering|October 20, 2022
Closed-loop optogenetic control of the dynamics of neural activity in non-human primatesB Zaaimi, M Turnbull, A Hazra, et al.British Journal of Cancer|August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100B P Schneider, L Li, F Shen, et al.British Journal of Haematology|November 3, 2025
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myelomaM R Seefat, D G J Cucchi, L van Boven, et al.Drug Delivery and Translational Research|January 17, 2020
Translational studies of intravenous and intracerebroventricular routes of administration for CNS cellular biodistribution for BMN 250, an enzyme replacement therapy for the treatment of Sanfilippo type BAnita Grover, Danielle Crippen-Harmon, Lacey Nave, et al.Proceedings of the National Academy of Sciences of the United States of America|June 2, 2005
The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)Margarita Garcia-Calvo, JeanMarie Lisnock, Herbert G Bull, et al.Journal of Medicinal Chemistry|June 23, 1999
Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinaseN J Liverton, J W Butcher, C F Claiborne, et al.Pageof 95